—

Dr. Reddy’s Laboratories Ltd ADR (RDY) — the peer cohort

As of 2026-10-06 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Dr. Reddy’s Laboratories Ltd ADR ranks 9 of 11 in its cohort on the Closelooknet composite (46/100) — the cohort is led by DexCom Inc at 65/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
RDY Dr. Reddy’s Laboratories Ltd ADR 46 29 44 63 info 19.5%
ROVI.MC Laboratorios Farmaceuticos ROVI 61 25 78 52 warn 31.8%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 55 91 58 42 ok 4.2%
ALM.MC Almirall S.A. 53 18 46 68 warn 26.2%
FAGR.BR Fagron NV 53 47 57 60 info 8.9%
APTX.TO Apotex Health Corp 46 34 59 50 — —
SFZN.SW Siegfried Holding Ltd 42 28 45 55 info 30.4%
DXCM DexCom Inc 65 78 81 37 bull 6.1%
ONC BeiGene, Ltd. 64 78 66 32 ok 5.8%
MEDP Medpace Holdings Inc 63 79 76 30 ok 11.1%
REGN Regeneron Pharmaceuticals Inc 60 56 72 51 watch 15.5%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-06

Quick answers

Who are Dr. Reddy’s Laboratories Ltd ADR's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Apotex Health Corp (APTX.TO), Siegfried Holding Ltd (SFZN.SW), DexCom Inc (DXCM), BeiGene, Ltd. (ONC) and others.

How does RDY score against its peers?

Dr. Reddy’s Laboratories Ltd ADR's composite reads 46/100, ranking 9 of 11 in its cohort as of 2026-10-06; the cohort's highest composite is DexCom Inc at 65/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.